HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Artesunate plus Amodiaquine

TERMINATED · PHASE4 · Malaria, Falciparum

Interim analysis showed more LCFs in one of the treatment arms

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.